“You have spent decades managing teams, businesses, and complex projects. You know how to delegate. You know how to lead. But when it comes to your health, you are often left deciphering cryptic lab reports or generic advice alone. Today, we change that structure. You are the CEO of your health. ChatGPT is about to… Continue reading Your Chief Medical Officer
Tag: Digital Health
Gene therapy approaches for Parkinson’s disease
Gene therapy approaches for Parkinson’s disease aim to modify or supplement gene expression to restore dopamine signaling, protect neurons, or modulate disease pathways. Recent advances show improved vector delivery, better safety profiles, and early signals of clinical benefit, though challenges remain around long-term efficacy, targeting, and scalability. Alzheimer’s & Neurodegeneration Education Series
Benefits of Nostalgia: How Memories Strengthen Us as We Age
Nostalgia isn’t just sentimentality—it’s neuroscience wrapped in memory.According to the University of Florida’s Psychology of Nostalgia (2025), revisiting positive past experiences activates brain regions linked to reward, social bonding, and emotional regulation. For older adults, these reflections can ease loneliness, boost mood, and help preserve cognitive function. When we reminisce, we reconnect with the people,… Continue reading Benefits of Nostalgia: How Memories Strengthen Us as We Age
Parkinson’s In Plain Language.
Overview Parkinson’s shows up differently for everyone. This quick read answers the five questions families ask first, with links you can use today. Keep it simple, repeatable, and share what you’re seeing with your care team. 1) Early signs? Tremor at rest, slowed movement, stiffness, small handwriting, and softer voice are common. Track when you… Continue reading Parkinson’s In Plain Language.
The Broader Context of Drug Repurposing
Introduction: Shifting the Paradigm in Alzheimer’s Research The landscape of Alzheimer’s disease (AD) research is undergoing a significant transformation. For decades, the focus has been on the amyloid hypothesis, with a multitude of clinical trials targeting amyloid-beta plaques, often with disappointing results. However, recent developments, including the NIA’s strategic funding of novel approaches, signal a… Continue reading The Broader Context of Drug Repurposing